Home/Pipeline/ClearView 2 Multifocal IOL

ClearView 2 Multifocal IOL

Cataract and Presbyopia Correction

CommercialActive

Key Facts

Indication
Cataract and Presbyopia Correction
Phase
Commercial
Status
Active
Company

About Lenstec

Lenstec is a well-established, privately-held medical device company that has been a significant player in the global ophthalmic market since 1993. The company's core business is the development and commercialization of a portfolio of intraocular lenses (IOLs), including monofocal (Softec series) and multifocal (ClearView series) lenses, alongside lens injection systems. A key differentiator is its commitment to manufacturing precision, often exceeding industry-standard power tolerances. With FDA approvals for key products and a global distribution footprint, Lenstec is positioned as an innovator focused on improving visual outcomes for patients and providing reliable tools for surgeons.

View full company profile

Therapeutic Areas

Other Cataract and Presbyopia Correction Drugs

DrugCompanyPhase
ClearView 3 Multifocal IOLLenstecApproved